Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Rogado, J. [1 ]
Pacheco-Barcia, V. [1 ]
Fenor De la Maza, M. D. [1 ]
Serra, J. M. [2 ]
Toquero, P. [1 ]
Vera, B. [1 ]
Obispo, B. [1 ]
Mondejar, R. [1 ]
Ballesteros, A. [1 ]
Donnay, O. [1 ]
Colomer, R. [1 ]
Sanchez-Torres, J. M. [1 ]
机构：
[1] Hosp Univ La Princesa, Oncol Med, Madrid, Spain
[2] Hosp Univ La Princesa, Farm Dept, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
anti PD-1; Nivolumab; Non-small-cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-057
引用
收藏
页码：S1915 / S1916
页数：2
相关论文
共 50 条
  • [41] NICE guidance on ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer
    Hall, Caroline J.
    Umeweni, Nwamaka
    Knight, Helen
    Smith, Lindsay
    [J]. LANCET ONCOLOGY, 2016, 17 (10): : 1357 - 1358
  • [42] Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer
    Socinski, Mark A.
    Novello, Silvia
    Brahmer, Julie R.
    Rosell, Rafael
    Sanchez, Jose M.
    Belani, Chandra P.
    Govindan, Ramaswamy
    Atkins, James N.
    Gillenwater, Heidi H.
    Pallares, Cinta
    Tye, Lesley
    Selaru, Paulina
    Chao, Richard C.
    Scagliotti, Giorgio V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 650 - 656
  • [43] Retrospective analysis of a group of patients with advanced Non-Small-Cell lung cancer (NSCLC) treated with Gefitinib
    Bandera, M.
    Bascialla, L.
    Martinelli, B.
    Masera, G. L. Rodolfo
    Vallini, I.
    Zanlorenzi, L.
    Pinotti, G.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 25 - 25
  • [44] Viagenpumatucel-L (HS-110) plus nivolumab in previously treated patients with advanced non-small cell lung cancer (NSCLC).
    Morgensztern, Daniel
    Bazhenova, Lyudmila
    Waqar, Saiama N.
    McDermott, Lori
    Hutchins, Jeff
    Harb, Wael
    Pennell, Nathan
    Cohen, Roger B.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 101 - 101
  • [45] Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina
    Martin, Claudio
    Lupinacci, Lorena
    Perazzo, Florencia
    Bas, Carlos
    Carranza, Omar
    Puparelli, Carmen
    Kowalyszyn, Ruben
    Magri, Ignacio
    Varela, Mirta
    Richardet, Eduardo
    Vera, Karina
    Foglia, Silvia
    Jerez, Ignacio
    Aman, Enrique
    Martinengo, Gaston
    Batagelj, Emilio
    Dri, Alejandro
    Pilnik, Norma
    Roa, Guillermo M.
    Mando, Pablo
    Tsou, Florencia
    Recondo, Gonzalo
    Cayol, Federico
    Flores, Marcos
    Sena, Susana
    Bagnes, Claudia
    Waisberg, Federico D.
    Minatta, Jose N.
    Rizzo, Manglio
    [J]. CLINICAL LUNG CANCER, 2020, 21 (05) : E380 - E387
  • [46] Nivolumab for Previously Treated Patients with Non-Small-Cell Lung Cancer-Daily Practice versus Clinical Trials
    Knetki-Wroblewska, Magdalena
    Kowalski, Dariusz M.
    Krzakowski, Maciej
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 10
  • [47] Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer
    Hasegawa, Takahiro
    Uno, Hajime
    Wei, Lee-Jen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05): : 492 - 492
  • [48] The real-world experience with nivolumab in previously treated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group clinical practice.
    Areses, M. C.
    Campelo, Rosario Garcia
    Gonzalez, Jorge Garcia
    Afonso, Francisco Javier
    Lazaro, Martin Emilio
    Campos, Begona
    Azpitarte, Cristina
    Amenedo, Margarita
    Santome, Lucia
    Ron, David Arias
    Alonso-Jaudenes, Guillermo
    Baron, Francisco
    Vilchez, Rocio
    Casal, Joaquin
    Fernandez, Natalia
    Carou, Iria
    Mosquera, Joaquin
    Anido, Urbana
    Mata, Jesus Garcia
    Firvida, Jose-Iuis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Gefitinib plus interleukin-2 (IL-2) in previously treated patients with advanced non-small-cell lung cancer (NSCLC)
    Buti, Sebastiano
    Chiesa, Matteo Dalla
    Tomasello, Gianluca
    Negri, Federica
    Machiavelli, Andrea
    Bosio, Giancarlo
    Stifani, Italo
    Betti, Monia
    Buononato, Massimo
    Passalacqua, Rodolfo
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 21 - 21
  • [50] Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab
    Putzu, Carlo
    Cortinovis, Diego Luigi
    Colonese, Francesca
    Canova, Stefania
    Carru, Ciriaco
    Zinellu, Angelo
    Paliogiannis, Panagiotis
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1349 - 1353
12345